These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2883094)

  • 1. [Anti-allergic effects of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole fumarate (KB-2413)].
    Saito T; Nishimura N; Tajima S; Fukuda T; Ito K
    Nihon Yakurigaku Zasshi; 1987 Feb; 89(2):55-62. PubMed ID: 2883094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
    Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiasthmatic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413), a new antiallergic.
    Fukuda T; Saito T; Ito K
    Arzneimittelforschung; 1984; 34(7):811-5. PubMed ID: 6149755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
    Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
    Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of YM-13650 on type I to type IV allergic reactions and immune responses in animals].
    Yamada T; Tomioka K; Mase T; Murase K
    Nihon Yakurigaku Zasshi; 1991 Feb; 97(2):75-84. PubMed ID: 1829062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6-ethyl-3-(1H-tetrazol-5-yl)chromone (AA-344) on the immediate and delayed hypersensitivity reactions.
    Kuriki H; Saijo T; Ashida Y; Maki Y
    Jpn J Pharmacol; 1979 Oct; 29(5):733-44. PubMed ID: 161338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of MY-5116 on experimental animal models of type I-type IV allergic reactions and the formation of IgE antibody].
    Takahashi K; Endoh K; Yamada N; Kadowaki S; Arai Y; Sugasawa K
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):245-54. PubMed ID: 2947841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action.
    Nagai H; Shimazawa T; Matsuura N; Koda A
    Jpn J Pharmacol; 1982 Oct; 32(5):813-22. PubMed ID: 6184511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of DS-4574, a new orally active antiallergic agent, in experimental allergic and inflammatory models.
    Aibara S; Mori M; Iwamoto T; Tsubokawa M; Takamori H; Tsukada W
    Jpn J Pharmacol; 1993 Apr; 61(4):267-76. PubMed ID: 8320873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M; Goto K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NIP-502 on antigen-induced bronchial responses and allergic reactions in animal models.
    Yamamoto A; Iwama T; Takeda H; Nagai H
    Jpn J Pharmacol; 1995 May; 68(1):47-55. PubMed ID: 7494382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of (+/-)-2-[p-(2-thenoyl)phenyl] propionic acid (suprofen) on experimental allergic reactions.
    Yokoya F; Nakayama T; Sakamoto K; Ohhira K; Ohshika Y; Mori Y; Toyoshi K; Nagai H; Koda A
    Jpn J Pharmacol; 1984 Jan; 34(1):23-31. PubMed ID: 6143845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
    Tomioka K; Yamada T; Mase T; Murase K
    Pharmacology; 1989; 39(1):28-38. PubMed ID: 2531424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
    Ueno M; Inagaki N; Nagai H; Koda A
    Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
    Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
    Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of KC-404 on allergic reactions types I-IV].
    Nishino K; Hara S; Irikura T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.